Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
Nicholas J. Vogelzang(Comprehensive Cancer Centers of Nevada), Russell K. Portenoy(Albert Einstein College of Medicine), David Cella(Northwestern University), William Breitbart(Memorial Sloan Kettering Cancer Center), S L Scherr, Loretta M. Itri(National Institutes of Health), Jerome E. Groopman(Harvard University), Douglas H. Johnson(Northern Prairie Wildlife Research Center), Gregory A. Curt(National Cancer Institute), Sandra J. Horning(Stanford University)
PubMed
July 1, 1997
Cited by 771
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
|Journal of Clinical Oncology|2003|3.1k